Skip to main content
Bruce Trapnell, MD, Pulmonology, Cincinnati, OH

Bruce Colston Trapnell MD

Pulmonology•Cincinnati, OH

Critical Care Medicine

Professor, Pediatrics, University of Cincinnati College of Medicine

Join to View Full Profile

  • 222 Piedmont AveSte 6000Cincinnati, OH 45219

  • Phone+1 513-475-7521

  • Fax+1 513-475-7327

Dr. Trapnell is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Trapnell's Full ProfileAlready have an account?

Education & Training

  • Clinical Center at the National Institutes of Health
    Clinical Center at the National Institutes of HealthFellowship, Pulmonary Disease and Critical Care Medicine, 1988 - 1989
  • Clinical Center at the National Institutes of Health
    Clinical Center at the National Institutes of HealthFellowship, Pulmonary Disease and Critical Care Medicine, 1987 - 1988
  • Ohio State University Hospital
    Ohio State University HospitalResidency, Internal Medicine, 1984 - 1987
  • University of Maryland School of Medicine
    University of Maryland School of MedicineClass of 1984

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 1998 - 2025
  • LA State Medical License
    LA State Medical License 2021 - 2022
  • DC State Medical License
    DC State Medical License 1992 - 1998
  • MD State Medical License
    MD State Medical License 1987 - 1991
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis  
    Bruce Trapnell, MD, New England Journal of Medicine

Press Mentions

  • HMN 2025: How Molgramostim Is Beneficial in Autoimmune Pulmonary Alveolar Proteinosis
    HMN 2025: How Molgramostim Is Beneficial in Autoimmune Pulmonary Alveolar ProteinosisAugust 24th, 2025
  • Inhaled Molgramostim Promising for Autoimmune Pulmonary Alveolar Proteinosis: Phase 3 Trial Shows
    Inhaled Molgramostim Promising for Autoimmune Pulmonary Alveolar Proteinosis: Phase 3 Trial ShowsAugust 22nd, 2025
  • Savara Announces New Data from Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Nebulizer Solution (Molgramostim) in Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Were Presented at the European Respiratory Society (ERS) Congress 2024
    Savara Announces New Data from Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Nebulizer Solution (Molgramostim) in Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Were Presented at the European Respiratory Society (ERS) Congress 2024September 8th, 2024
  • Join now to see all

Grant Support

  • Technology to understand genetic variant effects in contextUNIVERSITY OF WASHINGTON2019–2029
  • Versatile, exponentially scalable methods for single cell molecular profilingUNIVERSITY OF WASHINGTON2019–2028
  • New software tools for differential analysis of single-cell genomics perturbation experimentsUNIVERSITY OF WASHINGTON2023–2027
  • Human gene transfer & macrophage cell transplantation therapy of hereditary PAP (hPAP)CINCINNATI CHILDRENS HOSP MED CTR2021–2026
  • Human gene transfer & macrophage cell transplantation therapy of hereditary PAP (hPAP)CINCINNATI CHILDRENS HOSP MED CTR2021–2026
  • Retrospective Autoimmune PAP Natural History and Patient-Reported Outcomes StudyCINCINNATI CHILDRENS HOSP MED CTR2022–2025
  • Pathogenesis-Based Diagnostics and Pharmacotherapeutics for PAPCINCINNATI CHILDRENS HOSP MED CTR2007–2025
  • Interdisciplinary Training in Genome SciencesUNIVERSITY OF WASHINGTON1995–2025
  • Pulmonary Development and Disease Pathogenesis Training ProgramCINCINNATI CHILDRENS HOSP MED CTR1994–2025
  • Macrophage-Based Human Gene Therapy For Hereditary PAPNational Heart, Lung, And Blood Institute2011–2012
  • Quantitative Chest Computed Tomography In Alpha-1-Antitrypsin DeficiencyNational Center For Research Resources2008
  • Anticytokine Autoantibodies/Growth Factors In RARE Lung DiseasesNational Center For Research Resources2005–2008
  • RARE Lung Disease Clinical Research NetworkNational Center For Research Resources2003–2008
  • AAT Deficiency &Liver Diseases Caused By ProteinsNational Institute Of Diabetes And Digestive And Kidney Diseases2006
  • Fourth Annual International Pulmonary Alveolar Proteinosis Research ConferenceNational Heart, Lung, And Blood Institute2006
  • Regulation Of Alveolar Macrophage PhagocytosisNational Heart, Lung, And Blood Institute2003–2006
  • Pulmonary Alveolar Proteinosis Research ConferenceNational Heart, Lung, And Blood Institute2005
  • Conference--Pulmonary Alveolar Proteinosis ResearchNational Heart, Lung, And Blood Institute2004
  • GM-CSF &Alveolar Macrophage Antiviral Lung DefenseNational Heart, Lung, And Blood Institute2001–2004
  • Core--Viral VectorsNational Heart, Lung, And Blood Institute1997

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Bruce Trapnell, Dr. Bruce Trapnell, MD, Dr. B Trapnell, Dr. Bruce Colston Trapnell